Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Whole genome sequencing of Xenorhabdus griffiniae WS9

PROVIDER: PRJNA393299 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR5808430_1.fastq.gz	Fastqsanger.gz
	SRR5808430_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 2 of 2

Similar Datasets

RNA-seq profiling of wildtype Xenorhabdus griffiniae HGB2511 exposed to conventional and axenic Steinernema hermaphroditum nematodes.

Project description:Xenorhabdus griffiniae was grown for 24 hours with and without being in close proximity to their host nematode Steinernema hermaphrodtium.

2026-06-27 | GSE299917 | GEO

Xenorhabdus griffiniae

Project description:Xenorhabdus griffiniae overview

| PRJNA335477 | ENA

Xenorhabdus griffiniae strain:DSM 17911 | isolate:DSM 17911

Project description:Xenorhabdus griffiniae DSM 17911 genome sequencing

| PRJNA332158 | ENA

Xenorhabdus griffiniae strain:97

Project description:Xenorhabdus griffiniae strain:97 Genome sequencing

| PRJNA970755 | ENA

Xenorhabdus griffiniae strain:Kalro

Project description:Xenorhabdus griffiniae strain:Kalro Genome sequencing

| PRJNA970760 | ENA

Xenorhabdus griffiniae strain:BMMCB

Project description:Draft whole genome sequence of Xenorhabdus griffiniae strain BMMCB

| PRJNA283267 | ENA

Xenorhabdus griffiniae strain:XN45

Project description:Xenorhabdus griffiniae strain:XN45 Genome sequencing and assembly

| PRJNA663176 | ENA

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

Xenorhabdus griffiniae strain:HGB2511

Project description:Xenorhabdus griffiniae strain:HGB2511 Raw sequence reads

| PRJNA1274979 | ENA

Xenorhabdus griffiniae strain:HGB2511

Project description:Xenorhabdus griffiniae strain:HGB2511 Raw sequence reads

| PRJNA1274905 | ENA